S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q2 2026

Avoro Capital Advisors

Period: Q2 2026 Β· Filed: 2026-08-14
View on SEC EDGAR β†—
AUM
$11.14B
Total portfolio value
Positions
26
Reported securities
Top Holding
UTHR
13.5% $1.51B
QoQ Changes
+3 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 26 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$1.51B13.52%$541.83$499.73-7.8%
13.5%
ASNDASCENDIS PHARMA$1.36B12.24%$266.72$248.50-6.8%
12.2%
KRYSKRYSTAL BIOTECH INC$1.07B9.64%$371.67$332.27-10.6%
9.6%
MDGLMADRIGAL PHARMACEUTICALS INC$984.4M8.84%$536.95$507.56-5.5%
8.8%
ARGXARGENX SE$927.8M8.33%$927.77$851.29-8.2%
8.3%
ARWRARROWHEAD PHARMACEUTICALS INC$925.6M8.31%$81.51$86.64+6.3%
8.3%
KYMRKYMERA THERAPEUTICS INC$857.1M7.70%$114.67$117.39+2.4%
7.7%
RVMDREVOLUTION MEDICINES INC$430.2M3.86%$187.28$203.71+8.8%
3.9%
CYTKCYTOKINETICS INC$425.9M3.82%$85.19$74.13-13.0%
3.8%
CELCCELCUITY INC$355.7M3.19%$104.62$92.00-12.1%
3.2%
GPCRSTRUCTURE THERAPEUTICS INC$351.8M3.16%$53.67$54.51+1.6%
3.2%
XENEXENON PHARMACEUTICALS INC$348.8M3.13%$60.36$62.35+3.3%
3.1%
DFTXDEFINIUM THERAPEUTICS INC$338.2M3.04%$47.04$42.63-9.4%
3.0%
QUREUNIQURE NV$309.9M2.78%$46.06$48.62+5.6%
2.8%
VERAVERA THERAPEUTICS INC$245.6M2.21%$42.91$31.63-26.3%
2.2%
TSHATAYSHA GENE THERAPIES INC$162.7M1.46%$6.81$5.95-12.6%
1.5%
OCULOCULAR THERAPEUTIX INC$123.1M1.11%$9.82$10.04+2.2%
1.1%
DMRADAMORA THERAPEUTICS INC$98.4M0.88%$26.01$31.04+19.3%
0.9%
COAGHEMAB THERAPEUTICS HLDGS INC$70.7M0.63%$36.73$54.94+49.6%
0.6%
GHRSGH RESEARCH PLC$48.4M0.43%$26.88$29.49+9.7%
0.4%
VRDNVIRIDIAN THERAPEUTICS INC$45.9M0.41%$18.37$22.08+20.2%
0.4%
SEPNSEPTERNA INC$44.8M0.40%$33.49$44.50+32.9%
0.4%
AVTXAVALO THERAPEUTICS$43.1M0.39%$18.48$19.59+6.0%
0.4%
SNSEFAETH THERAPEUTICS INC$36.1M0.32%β€”β€”
0.3%
WHWKWHITEHAWK THERAPEUTICS INC$13.1M0.12%$4.58$4.46-2.6%
0.1%
LXEOLEXEO THERAPEUTICS INC$6.9M0.06%$4.66$4.84+3.9%
0.1%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (3)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA$1.36B-6.8%
COAGHEMAB THERAPEUTICS HLDGS INC$70.7M+49.6%
SNSEFAETH THERAPEUTICS INC$36.1M

Exited Positions (7)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA$1.16B-6.8%
APLSAPELLIS PHARMACEUTICALS INC$491.7M
CNTACENTESSA PHARMACEUTICALS PLC$454.0M
TERNTERNS PHARMACEUTICALS INC$300.2M
SLNOSOLENO THERAPEUTICS INC$77.0M
ALKSALKERMES PLC$42.4M
MNKDMANNKIND CORP$5.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CELCCELCUITY INC$352.7M+1600.0%-12.1%
UTHRUNITED THERAPEUTICS CORP$1.49B+631.0%-7.8%
VRDNVIRIDIAN THERAPEUTICS INC$16.6M+66.7%+20.2%
AVTXAVALO THERAPEUTICS$22.1M+65.5%+6.0%
CYTKCYTOKINETICS INC$206.3M+50.0%-13.0%
DFTXDEFINIUM THERAPEUTICS INC$243.7M+43.8%-9.4%
QUREUNIQURE NV$212.4M+12.9%+5.6%
TSHATAYSHA GENE THERAPIES INC$65.7M+10.1%-12.6%

Trimmed (3)

TickerIssuerNotionalShares Ξ”Since Filing
LXEOLEXEO THERAPEUTICS INC$-3.8M-20.6%+3.9%
VERAVERA THERAPEUTICS INC$8.7M-2.8%-26.3%
RVMDREVOLUTION MEDICINES INC$202.2M-2.0%+8.8%
← Back to Hedge Funds